Dr. Robert M. Bacigalupi, MD

Dr. Bacigalupi practices at All Island Dermatology in Garden City, New York.

Dr. Bacigalupi's NPI, 1740505668, was assigned on April 3, 2010. Dr. Bacigalupi graduated from Tulane School of Medicine in 2010. Dr. Bacigalupi holds New York license 274859.

Dr. Bacigalupi's primary practice is All Island Dermatology, at 54 New Hyde Park Rd, Garden City, NY 11530 in Nassau County. The practice phone is (516) 488-1313.

Dr. Bacigalupi's primary practice is All Island Dermatology in Garden City, New York. The medical group on file is All Island Dermatology, Plastic Surgery and Laser Center. Dmand AI also links Dr. Bacigalupi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bacigalupi practices, 2 sites in all. Vendor and product names are available with a free account.

Procedural dermatology is Dr. Bacigalupi's primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dr. Bacigalupi is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Bacigalupi's licenses on file in 3 states: New York, Florida and Louisiana.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, minor head injury, minor injury to a limb and scalp rash among the conditions Dr. Bacigalupi treats.

CMS data shows 2,204 Medicare services from Dr. Bacigalupi across 27 procedure codes in 2024, for 577 Medicare patients. Medicare paid $678,104 for them. Every service was in an office.

CMS counts 577 Medicare patients who saw Dr. Bacigalupi in 2024. The largest group is 75 to 84, with 236 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bacigalupi's median patient age at 66, with 49% women.

In 2024, Dr. Bacigalupi wrote 265 Medicare Part D claims for 136 patients. 99% of them were for generic drugs. CMS names the drug for 181 of them, across 7 drugs with 11 or more claims each, at $2,830 in total drug cost. In 2023, CMS named 180 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Bacigalupi for performance year 2024, reported as part of a group. Dr. Bacigalupi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 173 procedures of melanoma (skin cancer) excision by Dr. Bacigalupi, more than 97% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Bacigalupi, published from 2015 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Skin Neoplasms. Dr. Bacigalupi's most frequent co-authors are Hooman Khorasani, MD, Ronald Stephen Davis, MD and Danielle Pearl Dubin, MD.

CMS Open Payments shows 281 general payments to Dr. Bacigalupi from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 89% of the total. Galderma Laboratories, L.P. paid the most, $107,737.

Dr. Bacigalupi graduated from Tulane School of Medicine in 2010.

Dr. Bacigalupi is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.